Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Trevena Inc. | 2 | 26 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Evoke Pharma Inc. | 0 | 24 | 0 | 1 | €0.37 | - | - |
| Moleculin Biotech Inc | 3 | 26 | 0 | 3 | €0.41 | €18.42 | 4393.659% |
| Minerva Neurosciences Inc. | 0 | 13 | 0 | 3 | €2.50 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
| Organovo Holdings Inc. | 0 | 10 | 0 | 1 | €0.43 | - | - |
| Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Cyclacel Pharmaceuticals Inc. | 2 | 10 | 0 | 2 | €0.22 | €14.66 | 6565.591% |
| Glycomimetics Inc. | 3 | 10 | 0 | 3 | €0.14 | €9.13 | 6278.911% |
| Fibrogen Inc. | 0 | 1 | 0 | 0 | €0.35 | - | - |
| Coherus Bioscien. | 1 | 2 | 1 | 0 | €0.95 | - | - |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.74 | - | - |
| Cellectar BioSciences Inc. | 4 | 5 | 0 | 1 | €2.00 | €14.75 | 637.640% |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €5.80 | €58.50 | 908.621% |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Atara Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €0.37 | - | - |
| Palatin Technologies Inc. | 0 | 1 | 0 | 0 | €0.80 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Corbus Pharmaceuticals Holding Inc. | 1 | 1 | 0 | 0 | €17.50 | €50.00 | 185.714% |
| Bluebird Bio Inc. | 7 | 7 | 0 | 1 | €0.51 | €5.47 | 963.403% |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €2.90 | €7.31 | 151.996% |
| Aspira Womens Health Inc. | 1 | 1 | 0 | 0 | €0.73 | €4.99 | 588.607% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.05 | €50.00 | 4652.852% |
| Cara Therapeutics Inc. | 10 | 8 | 0 | 1 | €0.25 | €4.61 | 1763.813% |
| Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |